ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures
Insider Monkey
ResMed Inc. (RMD) is well-positioned for growth in the global obstructive sleep apnea (OSA) treatment market due to its robust product portfolio, including CPAP and APAP machines and accessories. Despite strong Q4 fiscal 2026 revenue growth, the company faces risks from increased competition, particularly Philips Respironics' potential return to the US market, and recently issued a weaker-than-expected 2027 revenue forecast. Investors are weighing ResMed's market leadership against these competi
Read the full story
This is a short summary. The complete article is published by Insider Monkey.
Headline and summary aggregated from public news feeds. For information only — not financial advice.